BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 7 Aug 2021)

Sexual behaviour, human papillomavirus and its vaccine: a qualitative study of adolescents and parents in Andalusia
Human papillomavirus (HPV) is one of the most common sexually transmitted infections and can be prevented by vaccination. The purpose of this study is to gain a better understanding, by analysing interview res…
Authors: María González-Cano, Francisco Garrido-Peña, Eugenia Gil-Garcia, Marta Lima-Serrano and María Dolores Cano-Caballero
Citation: BMC Public Health 2021 21:1476
Content type: Research article
Published on: 28 July 2021

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 7 Aug 2021)

Factors influencing childhood immunisation uptake in Africa: a systematic review
Vaccine preventable diseases are still the most common cause of childhood mortality, with an estimated 3 million deaths every year, mainly in Africa and Asia. An estimate of 29% deaths among children aged 1–59…
Authors: Abubakar Nasiru Galadima, Nor Afiah Mohd Zulkefli, Salmiah Md Said and Norliza Ahmad
Citation: BMC Public Health 2021 21:1475
Content type: Research article
Published on: 28 July 2021

BMJ Evidence-Based Medicine
August 2021 – Volume 26 – 4
https://ebm.bmj.com/content/26/4

Evidence synthesis
An evidence map of randomised controlled trials evaluating genetic therapies (10 November, 2020)
Genetic therapies replace or inactivate disease-causing genes or introduce new or modified genes. These therapies have the potential to cure in a single application rather than treating symptoms through repeated administrations. This evidence map provides a broad overview of the genetic therapies that have been evaluated in randomised controlled trials (RCTs) for efficacy and safety.
Eric A. Apaydin, Andrea S. Richardson, Sangita Baxi, Jerry Vockley, Olamigoke Akinniranye, Rachel Ross, Jody Larkin, Aneesa Motala, Gulrez Azhar, Susanne Hempel

BMJ Open
August 2021 – Volume 11 – 8
https://bmjopen.bmj.com/content/11/8

Original research: Correlates of intended COVID-19 vaccine acceptance across time and countries: results from a series of cross-sectional surveys (2 August, 2021)
John R Kerr, Claudia R Schneider, Gabriel Recchia, Sarah Dryhurst, Ullrika Sahlin, Carole Dufouil, Pierre Arwidson, Alexandra LJ Freeman, Sander van der Linden

Clinical Pharmacology & Therapeutics
Volume 110, Issue 2 Pages: 263-518 August 2021
https://ascpt.onlinelibrary.wiley.com/toc/15326535/current

Reviews
Free Access
Collaborative Platform Trials to Fight COVID-19: Methodological and Regulatory Considerations for a Better Societal Outcome
Olivier Collignon, Carl-Fredrik Burman, Martin Posch, Anja Schiel
Pages: 311-320
First Published:28 January 2021
Abstract
For the development of coronavirus disease 2019 (COVID-19) drugs during the ongoing pandemic, speed is of essence whereas quality of evidence is of paramount importance. Although thousands of COVID-19 trials were rapidly started, many are unlikely to provide robust statistical evidence and meet regulatory standards (e.g., because of lack of randomization or insufficient power). This has led to an inefficient use of time and resources. With more coordination, the sheer number of patients in these trials might have generated convincing data for several investigational treatments. Collaborative platform trials, comparing several drugs to a shared control arm, are an attractive solution. Those trials can utilize a variety of adaptive design features in order to accelerate the finding of life-saving treatments. In this paper, we discuss several possible designs, illustrate them via simulations, and also discuss challenges, such as the heterogeneity of the target population, time-varying standard of care, and the potentially high number of false hypothesis rejections in phase II and phase III trials. We provide corresponding regulatory perspectives on approval and reimbursement, and note that the optimal design of a platform trial will differ with our societal objective and by stakeholder. Hasty approvals may delay the development of better alternatives, whereas searching relentlessly for the single most efficacious treatment may indirectly diminish the number of lives saved as time is lost. We point out the need for incentivizing developers to participate in collaborative evidence-generation initiatives when a positive return on investment is not met.

Current Opinion in Infectious Diseases
August 2021 – Volume 34 – Issue 4
https://journals.lww.com/co-infectiousdiseases/pages/currenttoc.aspx

INFECTIONS OF THE IMMUNOCOMPROMISED HOST
Coronavirus disease 2019 vaccination in transplant recipients
Eberhardt, Christiane S.; Balletto, Elisa; Cornberg, Markus; More
Current Opinion in Infectious Diseases. 34(4):275-287, August 2021.

Developing World Bioethics
Volume 21, Issue 2 June 2021
https://onlinelibrary.wiley.com/toc/14718847/current

Special Issue: Conscientious objection to termination of pregnancy in the global south: legal and ethical challenges
Issue Edited by:  Anita Kleinsmidt

The European Journal of Public Health
SUPPLEMENT – Volume 31, Issue Supplement_1, July 2021
https://academic.oup.com/eurpub/issue/31/Supplement_1

Supplement: E-Mental-Health: Exploring the Evidence Base and Stakeholders’ Perspectives on Internet-Based Interventions for the Prevention of Mental Health Conditions
Mental illness represents an enormous personal, social and societal burden for European citizens1 calling for the need to expand existing models of mental healthcare delivery. In Europe, the Internet is a key source of health information,2 and technology-enhanced (psychological) interventions such as Internet- and mobile-delivered applications (‘eHealth’3 and ‘m-Health’4) have become increasingly popular and studied. There is already strong evidence of the efficacy of online interventions for the prevention and treatment of several psychological disorders5,6 and meta-analyses show effect sizes similar to face-to-face interventions.7

Gates Open Research
https://gatesopenresearch.org/browse/articles
[Accessed 7 Aug 2021]

Method Article metrics AWAITING PEER REVIEW
Looking in the medicine cabinet: methods for using real-world data to assess the impact of measles, mumps and rubella (MMR) and recombinant adjuvanted varicella-zoster vaccines on coronavirus disease 2019 (COVID-19) prevention and case fatality [version 1; peer review: awaiting peer review]
Douglas McNair, Hao Hu, Casey Selwyn
Peer Reviewers Invited
PUBLISHED 30 Jul 2021

Gates Open Research
https://gatesopenresearch.org/browse/articles
[Accessed 7 Aug 2021]

Open Letter metrics AWAITING PEER REVIEW
How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases [version 1; peer review: awaiting peer review]
Jessica Clark, Wilma A. Stolk, María-Gloria Basáñez, Luc E. Coffeng, Zulma M. Cucunubá, Matthew A. Dixon, Louise Dyson, Katie Hampson, Michael Marks, Graham F. Medley, Timothy M. Pollington, Joaquin M. Prada, Kat S. Rock, Henrik Salje, Jaspreet Toor, T. Déirdre Hollingsworth
Peer Reviewers Invited
Funders
Bill and Melinda Gates Foundation
UK Foreign, Commonwealth & Development Office
European and Developing Countries Clinical Trials Partnership (EDCTP2) programme
MRC Centre for Global Infectious Disease Analysis
UK Department for International Development
UK Medical Research Council
PUBLISHED 27 Jul 2021

Global Public Health
Volume 16, Issue 8-9 (2021)
http://www.tandfonline.com/toc/rgph20/current

Politics and pandemics
This Special Issue of Global Public Health on Politics & Pandemics brings together 26 articles and commentaries that address diverse aspects of the politics of COVID-19 and related issues. These papers are grouped together in six topical areas: theories and politics of global health, health systems and policies, country responses, social inequalities, social responses, and the politics of science and technology. The goal of the Special Issue is to give readers a sense of the range of topics that have been a focus for research in relation to the COVID-19 pandemic and to provide diverse examples of how research and analysis on the political dimensions of the pandemic can contribute to confronting the COVID-19 crisis.

Global Public Health
Volume 16, Issue 8-9 (2021)
http://www.tandfonline.com/toc/rgph20/current

Article
Global justice and the COVID-19 vaccine: Limitations of the public goods framework
Nivedita Saksena
Pages: 1512-1521
Published online: 25 Mar 2021
ABSTRACT
As vaccines for COVID-19 were first being approved for use, there were widespread calls for it to be assigned a ‘global public good’. However, allocating the COVID-19 vaccine globally poses a novel challenge of redistribution, one that cannot be effectively undertaken using current mechanisms for the dispensation of aid. An examination of the origins and implicit logic of global public goods theory shows that it would not be effective as a framework in this context. I argue that while it is a useful rhetorical tool to underscore the need for global access, it fails to account for concerns arising out of structural inequities between countries in the Global South and North. In addition to being ill-defined, the phrase encodes a neoliberal logic – one that prioritises the protection of private capital over democratic claims of redistribution and social justice. To ensure global access, our attention must be focussed instead on explicitly accounting for inequities, securing access for countries in the Global South and addressing the norm-setting powers of pharmaceutical companies.

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 7 Aug 2021]

Global infectious disease research collaborations in crises: building capacity and inclusivity through cooperation
The initial research requirements in pandemics are predictable. But how is it possible to study a disease that is so quickly spreading and to rapidly use that research to inform control and treatment?
Authors: Jonathon P. Fanning, Srinivas Murthy, Nchafatso G. Obonyo, J. Kenneth Baillie, Steve Webb, Heidi J. Dalton and John F. Fraser
Citation: Globalization and Health 2021 17:84
Content type: Commentary
Published on: 26 July 2021

Health Affairs
Vol. 40, No. 7 July 2021
https://www.healthaffairs.org/toc/hlthaff/current

July 2021 | Borders, Immigrants & Health
About one in seven residents of the US is an immigrant, and about fifteen million people live within 100 kilometers of the US-Mexico border. Disparities in health status exist between people born in the US and those who have immigrated. Immigration policy has been contentious throughout US history, and current policies in the US and Mexico have significant effects on the health and well-being of tens of millions of people. This thematic issue of Health Affairs focuses on immigrants and borders. The overview article by Arturo Vargas Bustamante and coauthors describes a range of health policy issues raised by the continuously shifting demography of US immigrants.

Humanitarian Exchange Magazine
Number 79, May 2021
https://odihpn.org/magazine/inclusion-of-persons-with-disabilities-in-humanitarian-action-what-now/

Localisation and local humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange is localisation+ and local humanitarian action. Five years ago this week, donors, United Nations (UN) agencies,  non-governmental organisations (NGOs), the International Committee of the Red Cross (ICRC) and International Federation of Red Cross and Red Crescent Societies (IFRC) committed within the Grand Bargain to increase multi-year investments in the institutional capacities of local and national responders, and to provide at least 25% of humanitarian funding to them as directly as possible. Since then, there is increasing consensus at policy and normative level, underscored by the Covid-19 pandemic, that local leadership should be supported.  Localisation has gone from a fringe conversation among policy-makers and aid agencies in 2016 to a formal priority under the Grand Bargain. Wider global movements on anti-racism and decolonisation have also brought new momentum to critical reflections on where power, knowledge and capacity reside in the humanitarian system. Yet progress has been slow and major gaps remain between the rhetoric around humanitarian partnerships, funding and coordination and practices on the ground.

JAMA
August 3, 2021, Vol 326, No. 5, Pages 373-450
https://jamanetwork.com/journals/jama/currentissue

Viewpoint
Potential Benefits of Expanded COVID-19 Surveillance in the US
David R. Holtgrave, PhD; Sten H. Vermund, MD, PhD; Leana S. Wen, MD, MSc
free access
JAMA. 2021;326(5):381-382. doi:10.1001/jama.2021.11211
This Viewpoint proposes several important areas of surveillance expansion by US public health agencies and other institutions for COVID-19 testing, vaccination, infection, and mortality rates.

JAMA Network
COVID-19 Update August 7, 2021

These articles on COVID-19 were published across the JAMA Network in the last week.

Journal of Health Care for the Poor and Underserved (JHCPU)
Volume 32, Number 2, May 2021 Supplement
https://muse.jhu.edu/issue/44396

Table of Contents
Overview of the Issue
Kevin B. Johnson, Tiffani J. Bright, Cheryl R. Clark
…The importance of techquity—defined as the strategic development and deployment of technology in health care and health to advance health equity—was even more apparent after the events of 2020. COVID-19 upended access to care and illuminated the impact of structural racism as a cause for a widening gap of access during the pandemic. Black Lives Matter became more than a trending hashtag on Twitter, or a movement resulting in peaceful protests and calls for policy reform: it put additional focus on the issue of race as a social and not a biological construct and called into question the rationale for common practices in health care that were triggered by race. A notable example was the emerging realization that kidney function assessment was tied to race and hardwired into many of our electronic health records. The real-world evidence around our lack of techquity was incontrovertible.
This Supplemental Issue of JHCPU provides articles that describe challenges to techquity, frameworks to improve the role of technology in care, and examples of how technology can transform health, public health, and health care…

Journal of Virology
Volume 95 Number 16 July 2021
http://jvi.asm.org/content/current

Spotlight
Articles of Significant Interest In This Issue
Poxviruses are exceptional in having a multicomponent entry-fusion complex (EFC) that is comprised of eleven conserved proteins embedded in the membrane of mature virions. Schin et al. (e00852-21) adapted the tripartite split green fluorescent protein complementation system to determine individual EFC protein contacts by proximity analysis within living cells. Previous EFC protein interactions were confirmed and new ones discovered and corroborated by additional methods. Most remarkable was the finding that the small, hydrophobic O3 protein interacted with each of the other EFC proteins, suggesting that multiple copies stabilize the complex within the viral membrane

The Lancet
Aug 07, 2021 Volume 398 Number 10299 p465-558, e9
https://www.thelancet.com/journals/lancet/issue/current

Comment
Measuring and ensuring routine childhood vaccination coverage
M Carolina Danovaro-Holliday, Katrina Kretsinger, Marta Gacic-Dobo

The Lancet
Aug 07, 2021 Volume 398 Number 10299 p465-558, e9
https://www.thelancet.com/journals/lancet/issue/current

Disruptions to childhood immunisation due to the COVID-19 pandemic
Kaja Abbas, Vittal Mogasale

The Lancet
Aug 07, 2021 Volume 398 Number 10299 p465-558, e9
https://www.thelancet.com/journals/lancet/issue/current

Articles
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1
GBD 2020, Release 1, Vaccine Coverage Collaborators
Open Access
Summary
Background
Measuring routine childhood vaccination is crucial to inform global vaccine policies and programme implementation, and to track progress towards targets set by the Global Vaccine Action Plan (GVAP) and Immunization Agenda 2030. Robust estimates of routine vaccine coverage are needed to identify past successes and persistent vulnerabilities. Drawing from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2020, Release 1, we did a systematic analysis of global, regional, and national vaccine coverage trends using a statistical framework, by vaccine and over time.
Methods
For this analysis we collated 55 326 country-specific, cohort-specific, year-specific, vaccine-specific, and dose-specific observations of routine childhood vaccination coverage between 1980 and 2019. Using spatiotemporal Gaussian process regression, we produced location-specific and year-specific estimates of 11 routine childhood vaccine coverage indicators for 204 countries and territories from 1980 to 2019, adjusting for biases in country-reported data and reflecting reported stockouts and supply disruptions. We analysed global and regional trends in coverage and numbers of zero-dose children (defined as those who never received a diphtheria-tetanus-pertussis [DTP] vaccine dose), progress towards GVAP targets, and the relationship between vaccine coverage and sociodemographic development.
Findings
By 2019, global coverage of third-dose DTP (DTP3; 81·6% [95% uncertainty interval 80·4–82·7]) more than doubled from levels estimated in 1980 (39·9% [37·5–42·1]), as did global coverage of the first-dose measles-containing vaccine (MCV1; from 38·5% [35·4–41·3] in 1980 to 83·6% [82·3–84·8] in 2019). Third-dose polio vaccine (Pol3) coverage also increased, from 42·6% (41·4–44·1) in 1980 to 79·8% (78·4–81·1) in 2019, and global coverage of newer vaccines increased rapidly between 2000 and 2019. The global number of zero-dose children fell by nearly 75% between 1980 and 2019, from 56·8 million (52·6–60·9) to 14·5 million (13·4–15·9). However, over the past decade, global vaccine coverage broadly plateaued; 94 countries and territories recorded decreasing DTP3 coverage since 2010. Only 11 countries and territories were estimated to have reached the national GVAP target of at least 90% coverage for all assessed vaccines in 2019.
Interpretation
After achieving large gains in childhood vaccine coverage worldwide, in much of the world this progress was stalled or reversed from 2010 to 2019. These findings underscore the importance of revisiting routine immunisation strategies and programmatic approaches, recentring service delivery around equity and underserved populations. Strengthening vaccine data and monitoring systems is crucial to these pursuits, now and through to 2030, to ensure that all children have access to, and can benefit from, lifesaving vaccines.
Funding
Bill & Melinda Gates Foundation.

The Lancet
Aug 07, 2021 Volume 398 Number 10299 p465-558, e9
https://www.thelancet.com/journals/lancet/issue/current

Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study
Kate Causey, et al
Open Access
Summary
Background
The COVID-19 pandemic and efforts to reduce SARS-CoV-2 transmission substantially affected health services worldwide. To better understand the impact of the pandemic on childhood routine immunisation, we estimated disruptions in vaccine coverage associated with the pandemic in 2020, globally and by Global Burden of Disease (GBD) super-region.
Methods
For this analysis we used a two-step hierarchical random spline modelling approach to estimate global and regional disruptions to routine immunisation using administrative data and reports from electronic immunisation systems, with mobility data as a model input. Paired with estimates of vaccine coverage expected in the absence of COVID-19, which were derived from vaccine coverage models from GBD 2020, Release 1 (GBD 2020 R1), we estimated the number of children who missed routinely delivered doses of the third-dose diphtheria-tetanus-pertussis (DTP3) vaccine and first-dose measles-containing vaccine (MCV1) in 2020.
Findings
Globally, in 2020, estimated vaccine coverage was 76·7% (95% uncertainty interval 74·3–78·6) for DTP3 and 78·9% (74·8–81·9) for MCV1, representing relative reductions of 7·7% (6·0–10·1) for DTP3 and 7·9% (5·2–11·7) for MCV1, compared to expected doses delivered in the absence of the COVID-19 pandemic. From January to December, 2020, we estimated that 30·0 million (27·6–33·1) children missed doses of DTP3 and 27·2 million (23·4–32·5) children missed MCV1 doses. Compared to expected gaps in coverage for eligible children in 2020, these estimates represented an additional 8·5 million (6·5–11·6) children not routinely vaccinated with DTP3 and an additional 8·9 million (5·7–13·7) children not routinely vaccinated with MCV1 attributable to the COVID-19 pandemic. Globally, monthly disruptions were highest in April, 2020, across all GBD super-regions, with 4·6 million (4·0–5·4) children missing doses of DTP3 and 4·4 million (3·7–5·2) children missing doses of MCV1. Every GBD super-region saw reductions in vaccine coverage in March and April, with the most severe annual impacts in north Africa and the Middle East, south Asia, and Latin America and the Caribbean. We estimated the lowest annual reductions in vaccine delivery in sub-Saharan Africa, where disruptions remained minimal throughout the year. For some super-regions, including southeast Asia, east Asia, and Oceania for both DTP3 and MCV1, the high-income super-region for DTP3, and south Asia for MCV1, estimates suggest that monthly doses were delivered at or above expected levels during the second half of 2020.
Interpretation
Routine immunisation services faced stark challenges in 2020, with the COVID-19 pandemic causing the most widespread and largest global disruption in recent history. Although the latest coverage trajectories point towards recovery in some regions, a combination of lagging catch-up immunisation services, continued SARS-CoV-2 transmission, and persistent gaps in vaccine coverage before the pandemic still left millions of children under-vaccinated or unvaccinated against preventable diseases at the end of 2020, and these gaps are likely to extend throughout 2021. Strengthening routine immunisation data systems and efforts to target resources and outreach will be essential to minimise the risk of vaccine-preventable disease outbreaks, reach children who missed routine vaccine doses during the pandemic, and accelerate progress towards higher and more equitable vaccination coverage over the next decade.
Funding
Bill & Melinda Gates Foundation.

Nature
Volume 596 Issue 7870, 5 August 2021
https://www.nature.com/nature/volumes/596/issues/7870

World View | 03 August 2021
Cash payments in Africa could boost vaccine uptake
When doses finally arrive, use cash incentives to overcome hesitancy.
Rabah Arezki

Nature
Volume 596 Issue 7870, 5 August 2021
https://www.nature.com/nature/volumes/596/issues/7870

Book Review | 02 August 2021
The COVID vaccine makers tell all
A book from the Oxford–AstraZeneca team, and a documentary, go behind the scenes in the race to vaccinate the world.
Heidi Ledford

New England Journal of Medicine
August 5, 2021 Vol. 385 No. 6
http://www.nejm.org/toc/nejm/medical-journal

Perspective
Contact Tracing for Covid-19 — A Digital Inoculation against Future Pandemics J. O’Connell and D.T. O’Keeffe

Pediatrics
August 01, 2021; Volume 148,Issue 2
https://pediatrics.aappublications.org/

Articles
Patient Portal Reminders for Pediatric Influenza Vaccinations: A Randomized Clinical Trial
Carlos Lerner, Christina Albertin, Alejandra Casillas, O. Kenrik Duru, Michael K. Ong, Sitaram Vangala, Sharon Humiston, Sharon Evans, Michael Sloyan, Craig R. Fox, Jonathan E. Bogard, Sarah Friedman, Peter G. Szilagyi
Pediatrics, Aug 2021, 148 (2) e2020048413

Pediatrics
August 01, 2021; Volume 148,Issue 2
https://pediatrics.aappublications.org/

From the American Academy of Pediatrics
Open Access
COVID-19 Vaccines in Children and Adolescents
Committee on Infectious Diseases
Pediatrics, Aug 2021, 148 (2) e2021052336

PLoS Biology
https://journals.plos.org/plosbiology/
(Accessed 7 Aug 2021)

Educating the future generation of researchers: A cross-disciplinary survey of trends in analysis methods
Taylor Bolt, Jason S. Nomi, Danilo Bzdok, Lucina Q. Uddin
Meta-Research Article | published 29 Jul 2021 PLOS Biology
https://doi.org/10.1371/journal.pbio.3001313

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 7 Aug 2021)

Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study
Jocelyn Chan, Heather F. Gidding, Christopher C. Blyth, Parveen Fathima, Sanjay Jayasinghe, Peter B. McIntyre, Hannah C. Moore, Kim Mulholland, Cattram D. Nguyen, Ross Andrews, Fiona M. Russell
Research Article | published 03 Aug 2021 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003733

PLoS Neglected Tropical Diseases
http://www.plosntds.org/

Research Article
Cost-effectiveness of dengue vaccination in Puerto Rico
Guido España, Andrew J. Leidner, Stephen H. Waterman, T. Alex Perkins
| published 26 Jul 2021 PLOS Neglected Tropical Diseases
https://doi.org/10.1371/journal.pntd.0009606

PLoS One
http://www.plosone.org/
[Accessed 7 Aug 2021]

Validation of a redesigned pan-poliovirus assay and real-time PCR platforms for the global poliovirus laboratory network
Hong Sun, Chelsea Harrington, Nancy Gerloff, Mark Mandelbaum, Stacey Jeffries-Miles, Lea Necitas G. Apostol, Ma. Anne-Lesley D. Valencia, Shahzad Shaukat, Mehar Angez, Deepa K. Sharma, Uma P. Nalavade, Shailesh D. Pawar, Elisabeth Pukuta Simbu, Seta Andriamamonjy, Richter Razafindratsimandresy, Everardo Vega
Research Article | published 06 Aug 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0255795

PLoS One
http://www.plosone.org/
[Accessed 7 Aug 2021]

Rotavirus A infection in pre- and post-vaccine period: Risk factors, genotypes distribution by vaccination status and age of children in Nampula Province, Northern Mozambique (2015-2019)
Assucênio Chissaque, Adilson Fernando Loforte Bauhofer, Idalécia Cossa-Moiane, Ezequias Sitoe, Benilde Munlela, Eva Dora João, Jerónimo S. Langa, Jorfélia José Chilaúle, Simone Salvador Boene, Marta Cassocera, Esperança Lourenço Guimarães, Timothy A. Kellogg, Luzia Gonçalves, Nilsa de Deus
Research Article | published 06 Aug 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0255720

PLoS One
http://www.plosone.org/
[Accessed 7 Aug 2021]

COVID-19 vaccine access and attitudes among people experiencing homelessness from pilot mobile phone survey in Los Angeles, CA
Randall Kuhn, Benjamin Henwood, Alexander Lawton, Mary Kleva, Karthik Murali, Coley King, Lillian Gelberg
Research Article | published 30 Jul 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0255246

PNAS – Proceedings of the National Academy of Sciences of the United States of America
July 27, 2021; vol. 118 no. 30
https://www.pnas.org/content/118/30

Microbiology
Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain
Daniela I. Staquicini, Fenny H. F. Tang, Christopher Markosian, Virginia J. Yao, Fernanda I. Staquicini, Esteban Dodero-Rojas, Vinícius G. Contessoto, Deodate Davis, Paul O’Brien, Nazia Habib, Tracey L. Smith, Natalie Bruiners, Richard L. Sidman, Maria L. Gennaro, Edmund C. Lattime, Steven K. Libutti, Paul C. Whitford, Stephen K. Burley, José N. Onuchic, Wadih Arap, and Renata Pasqualini
PNAS July 27, 2021 118 (30) e2105739118; https://doi.org/10.1073/pnas.2105739118

Science
06 August 2021 Vol 373, Issue 6555
http://www.sciencemag.org/current.dtl

In Depth
Taliban’s rise puts polio eradication in danger
By Leslie Roberts
Science06 Aug 2021 : 605-606 Restricted Access
U.S. departure from Afghanistan raises questions about future of vaccination drives.
Summary
The U.S. troop withdrawal from Afghanistan is imperiling the 3-decade global quest to eradicate polio. The Taliban, which now controls large swaths of the country, has blocked house-to-house polio vaccination in areas under its reign the past 3 years, putting up to 3 million children out of reach of the campaign. The Taliban may well wrest complete control from the Afghan government—which supports the eradication campaign—after U.S. forces are gone. But some inside and outside the Global Polio Eradication Initiative say a clear resolution to the conflict, regardless of who prevails, may actually aid eradication efforts. They hope the campaign will be able to work with the Taliban to keep vaccinations going if it consolidates power.

Vaccine
Volume 39, Issue 30 Pages 4013-4238 (5 July 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/30

Conference info Abstract only
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization
Minal K. Patel, Isabel Bergeri, Joseph S. Bresee, Benjamin J. Cowling, … Daniel R. Feikin
Pages 4013-4024

Vaccine
Volume 39, Issue 30 Pages 4013-4238 (5 July 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/30

Discussion Full text access
A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated
Sebastian Hoehl, Sandra Ciesek, Jürgen Graf, Sabine Wicker
Pages 4025-4026

Vaccine
Volume 39, Issue 30 Pages 4013-4238 (5 July 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/30

Discussion Full text access
One size does not fit all: Lessons from Israel’s Covid-19 vaccination drive and hesitancy
Aviad Raz, Yael Keshet, Ariela Popper-Giveon, Maha Sabbah Karkabi
Pages 4027-4028

Vaccine
Volume 39, Issue 30 Pages 4013-4238 (5 July 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/30

Discussion No access
Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label
Rafael Dal-Ré, Odile Launay
Pages 4029-4031

Vaccine
Volume 39, Issue 30 Pages 4013-4238 (5 July 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/30

Review article Abstract only
Charting mandatory childhood vaccination policies worldwide
Samantha Vanderslott, Tatjana Marks
Pages 4054-4062

Vaccine
Volume 39, Issue 30 Pages 4013-4238 (5 July 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/30

Research article Open access
Cost effectiveness of typhoid vaccination in India
Akashdeep Singh Chauhan, Isha Kapoor, Saroj Kumar Rana, Dilesh Kumar, … Shankar Prinja
Pages 4089-4098

Vaccine
Volume 39, Issue 30 Pages 4013-4238 (5 July 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/30

Research article Open access
School-based HPV vaccination positively impacts parents’ attitudes toward adolescent vaccination
Cristyn Davies, Tanya Stoney, Heidi Hutton, Adriana Parrella, … S. Rachel Skinner
Pages 4190-4198

Think Tanks et al
 
 
Brookings [to 7 Aug 2021]
http://www.brookings.edu/
FixGov
Vaccine mandates are more popular than you think
William A. Galston
Thursday, August 5, 2021

Interactive
COVID-19 vaccination efforts in the Middle East and North Africa
Paul Dyer, Isaac Schaider, and Andrew Letzkus
Tuesday, August 3, 2021
 
 
Center for Global Development [to 7 Aug 2021]
http://www.cgdev.org/page/press-center
Publications
Better Together: Exploring the Role of Pooled Procurement in Improving Access to Medicines amid COVID-19
August 2, 2021
Access to safe, effective, and affordable essential medicines is an integral global health goal, and all the more important during a public health emergency like COVID-19. Supply chain inefficiencies, procurement capacity constraints, and financial difficulties impede access to affordable, quality medicines; crises exacerbate these issues.
Julia Kaufman, Morgan Pincombe and Javier Guzman

The US Is Losing the Global War Against COVID-19—And That Is a National Security Issue
July 28, 2021
“The fight against COVID-19 is a global war but policymakers are not behaving accordingly. As a result… the scars will haunt our international relations for years to come.”
Masood Ahmed
 
 
Chatham House [to 7 Aug 2021]
https://www.chathamhouse.org/
Accessed 7 Aug 2021
[No new digest content identified]

 
 
CSIS
https://www.csis.org/
Accessed 7 Aug 2021
Podcast Episode
Chris Murray, IHME: “A Very Awkward Situation”
August 6, 2021 | By J. Stephen Morrison
Chris Murray, director of IHME, joined our podcast once again, at this major moment of reset of expectations – of our ability to control the pandemic, of policy decisions, data gaps, political attitudes and behavior, hitting the wall of hesitancy and refusal to vaccinate, and public confusion. We cover the full gamut: the forecast for the fall surge, missteps on masking, the need for greater transparency in data, and how much room exists to overcome resistance to vaccines.

Transcript
A Conversation with Dr. Anthony Fauci on the Antiviral Program for Pandemics
August 3, 2021

Report
U.S. Emergency Plan for Global Covid-19 Relief: Urgent Action to End the Pandemic Globally and Accelerate U.S. Recovery and Security
August 3, 2021

Podcast Episode
China’s Global Response to the COVID-19 Pandemic: A Conversation with Dr. Yanzhong Huang
August 3, 2021 | By Bonny Lin

Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
August 4, 2021 News Release
Most Unvaccinated Adults Don’t Believe the Vaccines are Very Effective and See the Vaccines as a Greater Health Risk than COVID-19 Itself
Vaccinated Adults Are Nearly Twice as Likely as Unvaccinated Ones to Worry that New Variants Like Delta Will Worsen the Pandemic Nationally and Locally As public health officials struggle to boost vaccination rates nationally, the latest KFF COVID-19 Vaccine Monitor reports that a narrow majority (53%) of unvaccinated adults believe…

August 2, 2021 News Release
Once Common, COVID-19 Deaths in Long-Term Care Were Rare across Most States in June
Early in the COVID-19 pandemic, residents and staff at nursing homes and other long-term care facilities accounted for a huge share of COVID deaths, but a new KFF analysis finds that they were relatively rare events across the country in June. The analysis finds that 13 states and the District…

July 30, 2021 News Release
COVID-19 Vaccine Breakthrough Cases Are Extremely Rare, According to KFF State Data Analysis
As COVID-19 cases increase along with spread of the more transmissible Delta variant, the effectiveness of COVID-19 vaccines continues to be an important topic. A new KFF analysis looks at COVID-19 vaccine “breakthrough cases,” when fully vaccinated individuals become infected, as well as hospitalizations and deaths, to see which states…